Showing results (591-600 of 1,376) with videos related to
Sort By:
Pageof 138
Neuro-Oncology Advances|January 10, 2024
Structural connectome-based predictive modeling of cognitive deficits in treated glioma patientsMichel Friedrich, Christian P Filss, Philipp Lohmann, et al.Neuro-Oncology Advances|September 18, 2024
Segmentation of pre- and posttreatment diffuse glioma tissue subregions including resection cavitiesSaif Baig, Igor Vidic, George M Mastorakos, et al.Neuro-Oncology Advances|February 27, 2024
Prediction of MGMT promotor methylation status in glioblastoma by contrast-enhanced T1-weighted intensity imageTakahiro Sanada, Manabu Kinoshita, Takahiro Sasaki, et al.Neuro-Oncology Advances|July 24, 2023
Brain metastasis screening in the molecular ageJoanna K Tabor, Amanda Onoichenco, Vinayak Narayan, et al.Neuro-Oncology Advances|July 18, 2023
Low-pass whole-genome and targeted sequencing of cell-free DNA from cerebrospinal fluid in pediatric patients with central nervous system tumorsKatrina O'Halloran, Venkata Yellapantula, Eirini Christodoulou, et al.Neuro-Oncology Advances|August 14, 2023
Erratum to: Dual-center validation of using magnetic resonance imaging radiomics to predict stereotactic radiosurgery outcomesNeuro-Oncology Advances|September 4, 2023
Erratum: This is a corrigendum to: Kumthekar et al, A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac123, https://doi.org/10.1093/noajnl/vdac123Neuro-Oncology Advances|August 21, 2023
Imaging telomerase reverse transcriptase expression in oligodendrogliomas using hyperpolarized δ-[1-13C]-gluconolactoneGeorgios Batsios, Celine Taglang, Anne Marie Gillespie, et al.Neuro-Oncology Advances|June 12, 2023
Corrigendum to: Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline gliomaPageof 138